glp 1 adoption GLP-1 Receptor Agonist Market Size GLP-1 Agonists Weight Loss Drugs

It is a scientifically studied peptide therapy that can help your body heal faster, recover stronger, and reduce inflammation

Schedule a Hair Loss Consultation to explore how advanced therapies can be tailored to your specific needs

Leonardo Cavone, Universit degli Studi di Firenze, Italy Copyright 2014 Schnekenburger, Karius and Diederich

Potential Demand for GLP-1s According to the Centers for Disease Control (CDC), in 2021, 29.4 million adults in the United States were diagnosed with diabetes (90 to 95 percent were T2D)

Level Strongest

Exenatide extended-release (Bydureon, Bydureon BCise) received FDA approval in 2012, offering once-weekly subcutaneous administration